Novo Resources Quote - NVO

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.115

Bid

0.10

Offer

0.115

Volume

0.00

0.00 Day's Range 0.00

0.081 52 Week Range 0.14

Market Cap

40.602M

Previous Close

0.115

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

154,590

Shares Outstanding

353,060,847

Dividend Yield

PE Ratio

-166.67

Earnings Per Share (EPS)

-0

Revenue

2.33M

Net Profit

-538k

Sector

Computer Related Svcs, Nec

Industry

Gold Ores

Website

www.nvoi.com.au

Headquarters

Sydney, New South Wales, Aus

Founded

2016

Novo Resources Corp is listed in the Computer Related Svcs sector of the Australian Stock Exchange with ticker NVO. The last closing price for Novo Resources was AUD0.12. Over the last year, Novo Resources shares have traded in a share price range of AUD 0.081 to AUD 0.14.

Novo Resources currently has 353,060,847 shares in issue. The market capitalisation of Novo Resources is AUD40.60 million. Novo Resources has a price to earnings ratio (PE ratio) of -166.67.

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

PRINCETON, N.J., Feb. 16 /PRNewswire-FirstCall/ -- Novo Nordisk (NYSE: NVO) today announced that Victoza® (liraglutide [rDNA origin] injection...

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Second Consecutive Year for Diabetes Care Leader PRINCETON, N.J., Jan. 21 /PRNewswire-FirstCall/ -- Novo Nordisk, a global healthcare company...

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

- Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 14 /PRNewswire/ -- A new analysis...

/K I L L K I L L K I L L - National Changing Diabetes Program/

We are advised by National Changing Diabetes Program that journalists and other readers should disregard the news release, Diabetes and...

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

- Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 13 /PRNewswire/ -- A new analysis...

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Study Shows Relief of Postmenopausal Symptoms PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk said today that the U.S. Food and...

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the...

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the...

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Primary Care Doctors, Endocrinologists Feel Ill-Equipped to Provide Ideal, Multi-Disciplinary Team Care PRINCETON, N.J., Nov. 19 /PRNewswire/...

Novo Nordisk is Changing Possibilities in Hemophilia

Expanded Web Site and Facebook Wall Provide Resources to Hemophilia with Inhibitors Community PRINCETON, N.J., Oct. 30 /PRNewswire-FirstCall/...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.01	9.52380952381	0.105	0.11	0.105	68565	0.10796227	DE
4	0.01	9.52380952381	0.105	0.11	0.099	61343	0.10491149	DE
12	0.015	15	0.1	0.12	0.094	154590	0.10368391	DE
26	0.017	17.3469387755	0.098	0.12	0.086	119481	0.09981601	DE
52	-0.015	-11.5384615385	0.13	0.14	0.081	138731	0.10068669	DE
156	-0.105	-47.7272727273	0.22	0.275	0.081	155704	0.14883761	DE
260	0.103	858.333333333	0.012	0.275	0.007	699495	0.03550067	DE

NVO - Frequently Asked Questions (FAQ)

What is the current Novo Resources share price?

The current share price of Novo Resources is AUD 0.115

How many Novo Resources shares are in issue?

Novo Resources has 353,060,847 shares in issue

What is the market cap of Novo Resources?

The market capitalisation of Novo Resources is AUD 40.6M

What is the 1 year trading range for Novo Resources share price?

Novo Resources has traded in the range of AUD 0.081 to AUD 0.14 during the past year

What is the PE ratio of Novo Resources?

The price to earnings ratio of Novo Resources is -166.67

What is the cash to sales ratio of Novo Resources?

The cash to sales ratio of Novo Resources is 37.88

What is the reporting currency for Novo Resources?

Novo Resources reports financial results in AUD

What is the latest annual turnover for Novo Resources?

The latest annual turnover of Novo Resources is AUD 2.33M

What is the latest annual profit for Novo Resources?

The latest annual profit of Novo Resources is AUD -538k

What is the registered address of Novo Resources?

The registered address for Novo Resources is LEVEL 5, 126 PHILLIP STREET, SYDNEY, NEW SOUTH WALES, 2000

What is the Novo Resources website address?

The website address for Novo Resources is www.nvoi.com.au

Which industry sector does Novo Resources operate in?

Novo Resources operates in the GOLD ORES sector

Symbol	Price	Vol.
OSLOOncoSil Medical Ltd	AUD 0.015 (1,400.00%)	500
ATXOAAmplia Therapeutics Limited	AUD 0.085 (325.00%)	16.25M
ATXAmplia Therapeutics Limited	AUD 0.23 (187.50%)	62.01M
ALAOArovella Therapeutics Limited	AUD 0.032 (113.33%)	965.21k
ADDAdavale Resources Limited	AUD 0.002 (100.00%)	2.02M
PCLOPancontinental Energy NL	AUD 0.001 (-50.00%)	1.06M
TVNOTivan Ltd	AUD 0.005 (-50.00%)	640
PNTOAPanther Metals Ltd	AUD 0.001 (-50.00%)	200k
ACWOCActinogen Medical Limited	AUD 0.007 (-36.36%)	667.48k
AXPAXP Energy Limited	AUD 0.001 (-33.33%)	161.24k
SNTSyntara Ltd	AUD 0.052 (-7.14%)	127.7M
AMIAurelia Metals ltd	AUD 0.2175 (-26.27%)	68.83M
ATXAmplia Therapeutics Limited	AUD 0.23 (187.50%)	62.01M
SYASayona Mining Limited	AUD 0.014 (-6.67%)	54.36M
GCMGreen Critical Minerals Ltd	AUD 0.0235 (-6.00%)	52.14M

Symbol

Price

Vol.

SNTSyntara Ltd

AUD 0.052

(-7.14%)

127.7M

AMIAurelia Metals ltd

AUD 0.2175

(-26.27%)

68.83M

ATXAmplia Therapeutics Limited

AUD 0.23

(187.50%)

62.01M

SYASayona Mining Limited

AUD 0.014

(-6.67%)

54.36M

GCMGreen Critical Minerals Ltd

AUD 0.0235

(-6.00%)

52.14M

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Novo Resources Corp (NVO)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Novo Resources Corp

Ask ADVFN Intelligence (AI)

NVO Latest News

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

/K I L L K I L L K I L L - National Changing Diabetes Program/

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Novo Nordisk is Changing Possibilities in Hemophilia

NVO - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Novo Resources Corp (NVO) Share Price

Novo Resources Corp (NVO)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Novo Resources Corp

Ask ADVFN Intelligence (AI)

NVO Latest News

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

/K I L L K I L L K I L L - National Changing Diabetes Program/

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Novo Nordisk is Changing Possibilities in Hemophilia

NVO - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Sign in

Go Ad-Free